A recent paper examines the circumstances in which public good outweighs the requirement that researchers receive individual consent to use a person's data.
The 2017 revisions to the Common Rule deal largely with improving the transparency and clarity of intended uses under the current standard of informed consent while introducing a new concept of "broad consent".
Cancer Therapy Advisor asked Dr Roberts about the PGen Study and the implications for DTC cancer risk testing in the future.
New methods of obtaining consent are offering options that can bridge the geographic distances between researcher and participant, while making study information more easily accessible.
Clinical Pain Advisor Articles
- Safety, Efficacy of Lidocaine Infusion for Prolonged Neuropathic Pain
- Assessing the Efficacy of Low-Dose Amitriptyline for Idiopathic Chronic Neck Pain
- CBT vs Pain Education for Chronic Pain in Low-Income Clinics
- Non-Opioid Therapies for Pain Management in the ED
- Trigger Point Dry Needling Plus Exercise Cost-Effective for Subacromial Pain Syndrome
- Exploring the Connections Between Neuropathic Pain and Comorbid Mood Disorders
- Medical Marijuana Laws, Dispensaries May Reduce Deaths From Opioid Overdose
- Ketamine Infusion May Be Effective for the Short-Term Relief of CRPS-Associated Pain
- An Avenue for the Development of Opioid Adjuncts for Enhanced Analgesia, Reduced Abuse Potential
- Spinal Manipulative Therapy May Effectively Reduce Cervicogenic Headache Days
- Chronic Pain in Adolescents and Alexithymia
- Bedside Quantitative Sensory Testing May Reliably Assess Sensory Profiles in Neuropathic Pain
- Peripheral Neuropathy Management in the Primary Care Setting: A Guide
- The Link Between Medical Malpractice and Defensive Medicine
- Drug Copayments Often Exceed Prescription Drug Costs